JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article


FIGURE 3. (A) HPLC after incubation of 18F-FECh with choline kinase and with choline oxidase. No-carrier-added 18F-FECh chloride was incubated with yeast choline kinase and 15 µmol ATP or with bacterial choline oxidase. From incubated specimen, methanol-water–soluble component was separated and fractionated on cation- and anion-exchange HPLC. 18F radioactivity was measured in each fraction. (B) HPLC after incubation of 18F-FECh with choline kinase and {gamma}-32P-ATP. No-carrier-added 18F-FECh chloride (approximately 0.005 µmol) was incubated with yeast choline kinase and 0.01 µmol {gamma}-32P-ATP. From incubated specimen, methanol-water–soluble component was separated and fractionated on anion-exchange HPLC. 18F and 32P radioactivities were measured in each fraction. kcpm = kilocounts per minute.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE